Canada markets closed

Aridis Pharmaceuticals, Inc. (ARDS)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0650+0.0020 (+3.17%)
At close: 03:07PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
19,602
0
0
0
Operating Expenses
Research Development
17,381
25,923
36,936
16,956
Selling General and Administrative
5,861
7,161
7,310
6,445
Total Operating Expenses
20,485
29,993
42,711
22,401
Operating Income or Loss
-883
-29,993
-42,711
-22,401
Total Other Income/Expenses Net
-436
-257
763
-9
Income Before Tax
-1,142
-30,371
-42,193
-22,333
Income from Continuing Operations
-1,142
-30,371
-42,193
-22,333
Net Income
-1,142
-30,371
-42,193
-22,333
Net Income available to common shareholders
-1,142
-30,371
-46,320
-22,333
Basic EPS
-0.12
-1.62
-3.85
-2.44
Diluted EPS
-0.16
-1.62
-3.85
-2.44
Basic Average Shares
32,173
18,777
12,292
9,169
Diluted Average Shares
40,885
18,777
12,292
9,169